Safilo Group SpA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IT0004604762
EUR
1.91
0.01 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Safilo Group SpA stock-summary
stock-summary
Safilo Group SpA
Pharmaceuticals & Biotechnology
Safilo Group SpA is an Italy-based holding company of the Safilo Group (the Group). The Group manufactures sunglasses and prescription eyewear and is engaged in the design, production, wholesale and retail distribution of products for the eyewear market. The Group operates a number of brands grouped into own brands and licensed brands. The Group's own brands consists of house brand collections of optical frames, sunglasses, technical glasses, ski goggles and helmets and includes the Safilo, Carrera, Polaroid, Smith Optics and Oxydo brands. The licensed brands portfolio includes Alexander McQueen, Banana Republic, BOSS, BOSS Orange, Bottega Veneta, Celine, Dior, Fossil, Gucci, HUGO, J.Lo by Jennifer Lopez, Jimmy Choo, Juicy Couture, Kate Spade, Liz Claiborne, Marc Jacobs, Marc by Marc Jacobs, Max Mara, Max&Co, Pierre Cardin, Saint Laurent, Saks Fifth Avenue and Tommy Hilfiger. It operates through 30 owned subsidiaries in America, Europe and Asia and through a network of distributors.
Company Coordinates stock-summary
Company Details
Settima Strada, 15 , PADOVA None : 35129
stock-summary
Tel: 39 04 9698511139 049 6985766
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Eugenio Razelli
Chairman of the Board
Mr. Angelo Trocchia
Chief Executive Officer
Dhr. Melchert Groot
Non-Executive Director
Mr. Jeffrey Cole
Non-Executive Independent Director
Ms. Catherine Gerardin-Vautrin
Non-Executive Independent Director
Mr. Guido Guzzetti
Non-Executive Independent Director
Ms. Ines Mazzilli
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
319 Million
(Quarterly Results - Dec 2015)
Net Profit:
-63 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 803 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-2.46%

stock-summary
Price to Book

2.00